slno,preds
0,"## Answer
The pathology report provides the following information:

- The tumor is a poorly differentiated invasive ductal carcinoma, which is classified as G3 (grade 3).
- The tumor size is 55 mm.
- There is invasion of lymph vessels (pLI) and blood vessels (pV1).
- There is infiltration of the overlying epidermis with slight erosion, indicating skin involvement, which is classified as pT4b.
- The tumor extends to the basal resection margin, indicating incomplete resection (R1).
- Lymph node involvement is noted as pN1a (1 out of 11 lymph nodes involved).
- Distant metastasis is not assessed (pMx).

According to the AJCC staging system:
- T4b indicates a tumor of any size with direct extension to the chest wall and/or skin (ulceration or skin nodules).
- N1a indicates metastasis to 1-3 axillary lymph nodes.
- Mx indicates that distant metastasis cannot be assessed.

Based on these findings, the cancer is classified as Stage IIIB, which corresponds to:
- T4 (tumor with chest wall or skin involvement)
- N1 (metastasis to 1-3 axillary lymph nodes)
- M0 or Mx (no distant metastasis or not assessed)

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
1,"## Answer
The pathology report provides the following information:

- Diagnosis: Breast Cancer
- Histological description: Infiltrative ductal carcinoma
- Grade: 2
- T Stage: 2
- N Stage: 0
- M Stage: 0

The AJCC staging system for breast cancer is based on the TNM classification:

- T (Tumor): T2 indicates a tumor size greater than 2 cm but not more than 5 cm.
- N (Nodes): N0 indicates no regional lymph node involvement.
- M (Metastasis): M0 indicates no distant metastasis.

Based on the TNM classification provided (T2, N0, M0), we can determine the AJCC stage:

- Stage I: T1, N0, M0
- Stage II: T2, N0, M0 or T1, N1, M0
- Stage III: T3, N0, M0 or T2, N1, M0, etc.
- Stage IV: Any T, Any N, M1

The patient's classification of T2, N0, M0 corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
2,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the TNM classification provided in the pathology report:

1. **Tumor (T) Classification**: 
   - The report states ""pT4b"". According to the AJCC staging system, T4b indicates a tumor of any size with direct extension to the chest wall and/or skin ulceration or skin nodules (excluding dermal infiltration alone).

2. **Node (N) Classification**: 
   - The report states ""N3a"". N3a indicates metastasis in 10 or more axillary lymph nodes, or in infraclavicular (level III axillary) lymph nodes.

3. **Metastasis (M) Classification**: 
   - The report does not mention distant metastasis (M0 or M1), but since it is not specified, we assume M0 (no distant metastasis).

4. **Additional Information**:
   - The report mentions ""multifocal"" tumors and ""focal angioinvasion"", but these do not directly affect the AJCC stage beyond the T, N, and M classifications.

Based on the TNM classification:
- T4b (tumor with skin ulceration)
- N3a (metastasis in 10 or more axillary lymph nodes)
- M0 (no distant metastasis assumed)

According to the AJCC 8th edition staging system for breast cancer:
- T4b, N3a, M0 corresponds to Stage IIIC.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
3,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor size (T):** The report mentions two foci of invasive lobular carcinoma measuring 1.9 cm and 2.2 cm. According to the AJCC 7th edition, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Nodes (N):** The report states that the axillary lymph nodes are negative (0/4 sentinel lymph nodes). This corresponds to N0, indicating no regional lymph node metastasis.

3. **Metastasis (M):** The report indicates MX, meaning distant metastasis cannot be assessed. However, there is no evidence of distant metastasis provided in the report.

Based on the TNM classification:
- T2 (tumor size between 2 and 5 cm)
- N0 (no regional lymph node involvement)
- MX (distant metastasis cannot be assessed, but no evidence provided)

According to the AJCC staging system, a T2, N0, M0 classification corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
4,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis based on the pathology report.

1. **Tumor Size (T):** 
   - The report indicates a moderately differentiated infiltrating ductal carcinoma with a microscopic distance of 2.6 cm. This corresponds to T2 (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N):**
   - Sentinel Node #1: Reactive lymph node with no evidence of metastatic disease.
   - Sentinel Node #2: Isolated tumor cell cluster, 0.1 mm, identified in a capsular lymphatic space. This is considered N0(i+) as it involves isolated tumor cells but not enough to be considered positive nodal involvement.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so M0.

Based on the above information:
- T2 (tumor size 2.6 cm)
- N0(i+) (isolated tumor cells in lymph node)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system, a T2 N0(i+) M0 breast cancer is classified as Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
5,"## Answer
To determine the AJCC stage of the cancer, we need to consider the T (tumor), N (nodes), and M (metastasis) classifications provided in the pathology report.

1. **T Stage (Tumor Size and Extent):** The report indicates a T stage of pT1b. According to AJCC, T1b refers to a tumor size greater than 0.5 cm but not more than 1 cm in greatest dimension. In this case, the tumor is 0.9 cm, which fits the T1b classification.

2. **N Stage (Lymph Node Involvement):** The N stage is pN0, which means there is no regional lymph node metastasis. The report confirms that both the sentinel and non-sentinel lymph nodes are negative for tumor involvement (0/1).

3. **M Stage (Distant Metastasis):** The M stage is pMX, indicating that distant metastasis cannot be assessed. However, there is no evidence of distant metastasis provided in the report.

Given these classifications:
- T1b: Tumor size greater than 0.5 cm but not more than 1 cm.
- N0: No regional lymph node metastasis.
- MX: Distant metastasis cannot be assessed, but no evidence of metastasis is provided.

According to the AJCC staging system, a combination of T1b, N0, and MX (with no evidence of distant metastasis) corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
6,"## Answer
The pathology report provides several key pieces of information that are crucial for determining the AJCC stage of the breast cancer:

1. **Tumor Size (T):** The primary tumor is described as infiltrating ductal carcinoma with a size of at least 3 cm in greatest dimension. According to AJCC staging, a tumor size of 2-5 cm corresponds to T2.

2. **Lymph Node Involvement (N):** The report indicates metastatic carcinoma in two of twenty-one lymph nodes. This corresponds to N1, which is defined as metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which suggests M0.

Based on the TNM classification:
- T2 (tumor size 2-5 cm)
- N1 (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

The combination of T2, N1, and M0 corresponds to Stage IIB according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
7,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor (T) Classification**: 
   - The report states ""pT1b(m)"". According to the AJCC 7th edition, T1b indicates a tumor size greater than 5 mm but not more than 10 mm. The main lesion is 6 mm, which fits this classification.

2. **Node (N) Classification**: 
   - The report states ""NO(sn)"", which means there is no regional lymph node metastasis. The sentinel lymph nodes examined (2 nodes) are negative for metastatic carcinoma (0/2).

3. **Metastasis (M) Classification**: 
   - The report states ""Mx"", indicating that distant metastasis cannot be assessed. However, there is no evidence provided in the report of distant metastasis.

Based on the TNM classification:
- T1b: Tumor size >5 mm but ≤10 mm.
- N0: No regional lymph node metastasis.
- Mx: Distant metastasis cannot be assessed, but no evidence of metastasis is provided.

According to the AJCC staging system, a T1b, N0, M0 classification corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
8,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report indicates an invasive ductal carcinoma in the left breast measuring 1.8 cm in largest dimension. According to AJCC staging, a tumor size of 1.8 cm falls under T1 (specifically T1c, which is >1 cm but ≤2 cm).

2. **Lymph Node Involvement (N):** The report states that all sentinel and non-sentinel lymph nodes examined from the left axilla are benign (0/1, 0/4, 0/1, 0/2), indicating no lymph node involvement. This corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Combining these factors, the cancer is classified as T1cN0M0, which corresponds to Stage I according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
9,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and metastasis status. The pathology report provides the following relevant information:

1. **Tumor Size**: The tumor is 3.0 cm in size. According to AJCC staging, a tumor size of 2-5 cm typically corresponds to T2.

2. **Lymph Node Involvement**: The report does not mention any lymph node involvement. In the absence of lymph node involvement information, we assume N0 (no regional lymph node metastasis).

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size 2-5 cm)
- N0 (no lymph node involvement mentioned)
- M0 (no distant metastasis mentioned)

According to the AJCC staging system for breast cancer:
- T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
10,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor Size (T):** The report mentions two invasive carcinoma masses: one with a size of 1.0 x 1.0 x 0.6 cm and another separate mass of 2.5 cm. The largest invasive component is considered for staging, which is 2.5 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report states that sentinel lymph nodes #1 and #2 are negative for tumor (0/1 and 0/1), and axillary lymph nodes are also negative for tumor (0/2). This indicates no regional lymph node metastasis, classifying it as N0.

3. **Distant Metastasis (M):** The report indicates MX, meaning distant metastasis cannot be assessed. However, for staging purposes, we assume M0 unless there is evidence of metastasis.

Given the classification of pT2, N0, MX, the cancer is staged as Stage II according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
11,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Characteristics**: The invasive tumor is 3.5 cm in its greatest dimension, which corresponds to a T2 classification (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement**: There are 3 out of 28 lymph nodes positive for metastatic adenocarcinoma, with extracapsular extension noted. This corresponds to an N1 classification (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis**: The M stage is reported as pMX, indicating that distant metastasis cannot be assessed from the provided information.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: Typically involves T1 tumors with no lymph node involvement (N0).
- **Stage II**: Includes T2 tumors with N0 or N1 lymph node involvement.
- **Stage III**: Generally involves larger tumors (T3 or T4) or more extensive lymph node involvement (N2 or N3).
- **Stage IV**: Indicates the presence of distant metastasis (M1).

Given the T2 classification, N1 lymph node involvement, and no confirmed distant metastasis (pMX), the cancer is best classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
12,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the pathology report using the TNM classification system:

1. **Tumor Size and Extent (T):** 
   - The report mentions ""bifocal poorly differentiated invasive ductal carcinoma"" with tumor diameters of 2.5 cm and 0.7 cm. 
   - The classification given is ""pT2(mult),"" which indicates multiple tumors with the largest being greater than 2 cm but not more than 5 cm in greatest dimension.

2. **Lymph Node Involvement (N):**
   - The report states ""NO(sn),"" which means there is no regional lymph node metastasis detected (N0).

3. **Distant Metastasis (M):**
   - The report does not mention any distant metastasis, and the classification ""ORO"" suggests no distant metastasis (M0).

4. **Overall Stage:**
   - According to the AJCC staging system, a T2, N0, M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
13,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor Size (T):** The report states ""PTNM stage: T2N1MX."" The ""T2"" classification indicates that the tumor is more than 2 cm but not more than 5 cm in greatest dimension. The specific size given is 2.5 x 2 x 1.8 cm, which fits within the T2 category.

2. **Lymph Node Involvement (N):** The ""N1"" classification indicates that there is metastasis to 1-3 axillary lymph nodes. The report confirms this with ""Sentinel, 1/2; Level 1 and II, 1/8,"" indicating that there is involvement of lymph nodes.

3. **Metastasis (M):** The ""MX"" classification means that distant metastasis cannot be assessed. However, there is no indication of distant metastasis in the report.

Based on the TNM classification:
- T2 indicates a tumor size that is more than 2 cm but not more than 5 cm.
- N1 indicates metastasis to 1-3 axillary lymph nodes.
- MX indicates that distant metastasis cannot be assessed, but there is no evidence of distant metastasis provided.

According to the AJCC staging system, a T2N1MX classification corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
14,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is described as pT2, which indicates a tumor size greater than or equal to 2.0 cm but less than or equal to 5.0 cm.

2. **Regional Lymph Nodes (N):** The report states pN1a, which means there is metastasis in 1 to 3 axillary lymph nodes, with at least one tumor deposit greater than 2.0 mm. In this case, 2 out of 13 lymph nodes are involved.

3. **Distant Metastasis (M):** The report indicates pMX, meaning distant metastasis cannot be assessed.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I** typically involves T1 (tumor ≤ 2 cm) and N0 (no regional lymph node involvement).
- **Stage II** can involve T2 with N0 or N1 (1-3 lymph nodes involved).
- **Stage III** involves larger tumors (T3 or T4) or more extensive lymph node involvement (N2 or N3).
- **Stage IV** involves any T, any N, and M1 (distant metastasis present).

Given the information:
- The tumor size is T2.
- There is involvement of 1-3 lymph nodes (N1).
- Distant metastasis cannot be assessed (MX).

This combination of T2, N1, and MX corresponds to **Stage II** breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
15,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states ""Infiltrating ductal carcinoma... forming a mass (2.2 x 1.6 x 1.6 cm)"" and ""[AJCC pT2]."" According to AJCC staging, a pT2 tumor is greater than 2 cm but not more than 5 cm in greatest dimension.

2. **Lymph Node Involvement (N):** The report mentions ""Multiple (5) right axillary sentinel lymph nodes are negative for metastatic carcinoma [AJCC pNO (i-) (sn)]."" This indicates that there is no regional lymph node metastasis, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer:
- T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
16,"## Answer
To determine the AJCC stage of the cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report states that the tumor in the right breast is 1.3 by 1.2 by 1.0 cm. According to AJCC staging, a tumor size of 2 cm or less is classified as T1.

2. **Lymph Node Involvement (N):** The report indicates that one out of twenty-three right axillary lymph nodes has metastatic carcinoma with extracapsular extension. This suggests lymph node involvement. According to AJCC staging, involvement of 1-3 axillary lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T1 (tumor size ≤ 2 cm)
- N1 (1-3 lymph nodes involved)
- M0 (no distant metastasis)

According to the AJCC staging system, a combination of T1, N1, and M0 corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
17,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive lobular carcinoma is 3.0 cm in greatest dimension. According to the AJCC 8th edition, this corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** There are 3 lymph nodes examined, with 1 node showing macrometastasis (9 mm) and 1 node showing micrometastasis (1 mm). This corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the TNM classification provided in the report (pT2 N1a M0), we can determine the stage:

- **Stage I:** Typically involves T1 or T2 with N0.
- **Stage II:** Typically involves T2 with N1 or T3 with N0.
- **Stage III:** Typically involves T3 with N1 or any T with N2 or N3.
- **Stage IV:** Involves any T, any N, and M1.

Given the classification pT2 N1a M0, this corresponds to Stage II according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
18,"## Answer
The pathology report provides the following information:

1. The tumor is highly differentiated, which corresponds to a lower grade (G I).
2. The tumor size is 9 cm, which is significant for staging.
3. The tumor classification is pT3N0M0.

Let's break down the classification:

- **pT3**: This indicates that the tumor is more than 5 cm in greatest dimension. In this case, the tumor is 9 cm, which fits the pT3 category.
- **N0**: This indicates that there is no regional lymph node metastasis.
- **M0**: This indicates that there is no distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: Typically involves smaller tumors (T1) and no lymph node involvement (N0).
- **Stage II**: Involves larger tumors (T2 or T3) with or without lymph node involvement (N0 or N1).
- **Stage III**: Involves larger tumors (T3 or T4) with more significant lymph node involvement (N1, N2, or N3).
- **Stage IV**: Involves any T, any N, and M1 (distant metastasis present).

Given the classification of pT3N0M0, the tumor is large (T3) but has no lymph node involvement (N0) and no distant metastasis (M0). This fits the criteria for Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
19,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size and Type**: The right breast has two tumors, both invasive lobular carcinoma, each measuring 1.0 cm in greatest dimension. The pathologic stage is noted as pT1c, which corresponds to a tumor size greater than 1 cm but not more than 2 cm.

2. **Lymph Node Involvement**: The report indicates that four out of four lymph nodes are positive for tumor involvement. Specifically, three sentinel lymph nodes and one non-sentinel lymph node in the right axilla are positive for carcinoma, with extracapsular extension noted in the non-sentinel node. This corresponds to N2, which indicates metastasis to 4-9 axillary lymph nodes.

3. **Distant Metastasis**: The report does not provide information on distant metastasis (MX), meaning it is not assessed.

According to the AJCC 6th edition staging system:
- **Stage I**: T1, N0, M0
- **Stage II**: T2 or T3, N0 or N1, M0
- **Stage III**: Any T, N2, M0 or T3, N1, M0
- **Stage IV**: Any T, Any N, M1

Given the information:
- The tumor size and lymph node involvement (pT1c N2 MX) align with Stage III, as there is involvement of 4 lymph nodes (N2) and no assessment of distant metastasis (MX).

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
20,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The invasive ductal carcinoma in the right breast measures 1.5 cm in greatest dimension. This size is relevant for staging, particularly for T (tumor) classification.

2. **Lymph Node Involvement**: There is a single keratin-positive cell suspicious for an isolated tumor cell in one sentinel lymph node, but no tumor is identified in the other lymph node. This suggests N0(i+) status, which indicates isolated tumor cells in lymph nodes but not enough to be considered positive for metastasis.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, suggesting M0 status.

4. **Histologic Grade**: The tumor is high nuclear grade, Nottingham histologic grade 3, which indicates a more aggressive tumor but does not directly affect the AJCC stage.

5. **Receptor Status**: The tumor is low positive for estrogen receptor (5%), negative for progesterone receptor, and has a high Ki-67 index (50%), indicating a high proliferation rate. These factors are more relevant for treatment decisions rather than staging.

Based on the AJCC 8th edition criteria for breast cancer staging:
- T1c: Tumor size >1 cm but ≤2 cm.
- N0(i+): Isolated tumor cells in lymph nodes.
- M0: No distant metastasis.

The combination of T1c, N0(i+), and M0 corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
21,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report mentions three masses measuring 2.0 cm, 1.9 cm, and 1.1 cm. The largest tumor is 2.0 cm. According to AJCC, a tumor size of 2.0 cm falls under T1 (specifically T1c, which is >1 cm but ≤2 cm).

2. **Lymph Node Involvement (N):** 
   - Metastatic adenocarcinoma is found in one of one sentinel lymph node, with a maximum size of metastasis of 0.3 cm.
   - Metastatic adenocarcinoma is also found in one of one palpable lymph node in the left axilla, with a maximum size of metastasis of 0.9 cm and extranodal extension present.
   - Additionally, metastatic adenocarcinoma is found in three of thirty-one lymph nodes in the left axillary contents, with a maximum size of metastasis of 0.4 cm and extranodal extension present.
   - This indicates significant lymph node involvement, which corresponds to N2 (metastasis in 4-9 axillary lymph nodes or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so M0 is assumed.

Combining these, the staging would be T1c N2 M0, which corresponds to Stage IIIA according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
22,"## Answer
To determine the AJCC stage of the cancer, we need to consider the T (Tumor), N (Node), and M (Metastasis) stages provided in the pathology report.

1. **T Stage (Tumor):** The report states ""T Stage: 2"". This indicates that the primary tumor is classified as T2, which generally means the tumor is larger than 2 cm but not more than 5 cm in greatest dimension.

2. **N Stage (Node):** The report states ""N Stage: 1"". This indicates that there is involvement of regional lymph nodes, specifically N1, which typically means metastasis to movable ipsilateral axillary lymph nodes.

3. **M Stage (Metastasis):** The report states ""M Stage: 0"". This indicates that there is no distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:
- **Stage I** typically involves T1, N0, M0.
- **Stage II** can involve T2, N0, M0 or T1-T2, N1, M0.
- **Stage III** involves more advanced combinations such as T3, N0-N1, M0 or any T, N2, M0.
- **Stage IV** involves any T, any N, M1.

Given the T2, N1, M0 classification, this corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
23,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and metastasis status. The pathology report provides the following information:

1. **Tumor Size**: The report mentions a white and firm area measuring 0.4 cm in the largest diameter. This indicates a small tumor size.

2. **Lymph Node Involvement**: The report does not mention any lymph node involvement. In the absence of this information, we assume there is no lymph node involvement.

3. **Metastasis**: There is no mention of distant metastasis in the report.

Based on the AJCC staging system for breast cancer:
- **Stage I** typically involves a tumor size of up to 2 cm with no lymph node involvement and no distant metastasis.
- **Stage II** involves a larger tumor size or limited lymph node involvement.
- **Stage III** involves more extensive lymph node involvement or a larger tumor.
- **Stage IV** involves distant metastasis.

Given the tumor size of 0.4 cm, no lymph node involvement, and no distant metastasis, the cancer is consistent with **Stage I**.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
24,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor Size (T):** The report indicates a tumor size of 2.5 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report states ""There is no evidence of malignancy in either of 2 lymph nodes,"" which corresponds to N0, indicating no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0.

Based on the TNM classification:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, a T2 N0 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
25,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (pT):** The tumor is classified as pT3, which indicates a tumor greater than 50 mm in greatest dimension. In this case, the tumor is 7.0 cm (70 mm).

2. **Regional Lymph Nodes (pN):** The report states pN0, meaning no regional lymph node metastasis was identified histologically. Two sentinel lymph nodes were examined, and both were negative for malignancy.

3. **Distant Metastasis (pM):** The report indicates ""Not applicable"" for distant metastasis, which typically means there is no evidence of distant metastasis (pM0).

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I** typically involves smaller tumors (≤2 cm) with no lymph node involvement.
- **Stage II** involves larger tumors (2-5 cm) or small tumors with limited lymph node involvement.
- **Stage III** involves larger tumors (>5 cm) or any size tumor with significant lymph node involvement.
- **Stage IV** involves any tumor size with distant metastasis.

Given the tumor size of 7.0 cm (pT3) and no lymph node involvement (pN0), the cancer is classified as Stage II. Stage III would require either lymph node involvement or a larger tumor with more extensive local spread, which is not the case here.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
26,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states that the tumor is 1.6 x 1.5 x 1.3 cm, which corresponds to AJCC pT1c. According to AJCC staging, T1c indicates a tumor size greater than 1 cm but not more than 2 cm.

2. **Lymph Node Involvement (N):** The report mentions that the right sentinel lymph node is negative for tumor, indicating no regional lymph node involvement (N0).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T1c (tumor size >1 cm but ≤2 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC 8th Edition Cancer Staging Manual for breast cancer, a T1c, N0, M0 classification corresponds to Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
27,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The tumor is described as a poorly differentiated infiltrating ductal carcinoma with a maximum dimension of 3 cm. This corresponds to a T2 classification (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement**: There is one positive sentinel lymph node (1/1), which corresponds to an N1 classification (metastasis to 1-3 axillary lymph nodes).

3. **Metastasis**: The report indicates MX, meaning distant metastasis cannot be assessed.

4. **PTNM Classification**: The report explicitly states the classification as Stage IIB, T2 N1 MX.

Based on the AJCC staging system, the combination of T2 N1 MX corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
28,"## Answer
The pathology report provides the following key information:

1. **Primary Tumor (T):** The invasive lobular carcinoma involves an area of approximately 8.5 cm in the lateral aspect of the left breast. This size suggests a T2 or T3 classification, as T2 is for tumors >2 cm but ≤5 cm, and T3 is for tumors >5 cm.

2. **Regional Lymph Nodes (N):** Metastatic carcinoma is present in one sentinel lymph node and in nine of twenty-one axillary lymph nodes. The presence of metastasis in 10 lymph nodes (1 sentinel + 9 axillary) indicates an N2 classification, as N2 is for metastasis in 4-9 axillary lymph nodes or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, suggesting an M0 classification.

Based on the AJCC staging system for breast cancer:
- T3 (tumor >5 cm)
- N2 (metastasis in 4-9 axillary lymph nodes)
- M0 (no distant metastasis)

This combination corresponds to Stage III breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
29,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report indicates the tumor is 1.3 x 1.3 x 1.2 cm, which corresponds to AJCC pT1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report states that multiple (2) right axillary sentinel lymph nodes are negative for metastatic carcinoma, which corresponds to AJCC pN0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the AJCC 8th edition staging system for breast cancer:
- T1c
- N0
- M0

This combination corresponds to Stage I breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
30,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is described as an infiltrating ductal carcinoma, moderately differentiated, with a size of 2.0 cm in greatest dimension. According to the AJCC 8th edition, a tumor size of more than 1 cm but not more than 2 cm is classified as T1c.

2. **Regional Lymph Nodes (N):** The report indicates that no carcinoma was seen in any of the examined lymph nodes (0/11), and the pathologic staging is pN0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** The report states ""Mx,"" indicating that distant metastasis cannot be assessed, but there is no evidence provided of distant metastasis.

Based on the TNM classification:
- T1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension.
- N0: No regional lymph node metastasis.
- Mx: Distant metastasis cannot be assessed, but no evidence of distant metastasis is provided.

Given these findings, the cancer is classified as Stage I according to the AJCC staging system, which corresponds to T1c N0 M0.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
31,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size and Extent (T):** 
   - The report indicates a mass of size 9.2 x 4.2 x 3.2 cm, which is classified as pT3. According to AJCC, T3 indicates a tumor larger than 5 cm.

2. **Lymph Node Involvement (N):**
   - The report states that multiple (4) left axillary sentinel lymph nodes are negative for metastatic carcinoma, classified as pN0. This means there is no regional lymph node involvement.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, which implies M0.

Based on the above information:
- T3 (tumor larger than 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer:
- Stage I typically involves T1 or T2 with N0 and M0.
- Stage II can involve T2 or T3 with N0 or N1 and M0.
- Stage III involves larger tumors or more extensive lymph node involvement.
- Stage IV involves distant metastasis.

Given the classification of T3, N0, M0, the cancer falls into Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
32,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report states that the invasive ductal carcinoma is 3.5 cm in greatest dimension. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The pathology report indicates metastatic carcinoma in 2 of 14 lymph nodes, with the largest metastasis being 3.4 cm and extracapsular extension present. This corresponds to N1, which is defined as metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size 3.5 cm)
- N1 (metastasis in 2 lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
33,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive lobular carcinoma measures 2.6 cm in greatest dimension. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The sentinel lymph nodes are negative for carcinoma (0/2), indicating no regional lymph node metastasis. This corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0.

Based on the TNM classification:
- T2 (tumor size >2 cm but ≤5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

The combination of T2, N0, and M0 corresponds to Stage II according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
34,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The tumor is described as 4.3 x 2.3 x 2.7 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates ""Metastases carcinomatosae in lymphonodis axillae (No II/XVII),"" meaning there are cancer metastases in 2 out of 17 axillary lymph nodes. This corresponds to N1, which is defined as metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the TNM classification:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
35,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Characteristics**: The left breast has multicentric in situ and infiltrating lobular carcinoma. The invasive carcinoma spans a gross distance of 7.0 cm from medial to lateral in the superior central portion of the specimen, with a distinct and separate 1.0 cm nodule of invasive lobular carcinoma in the upper outer quadrant. The tumor is nuclear grade II/III with a low mitotic index.

2. **Lymph Node Involvement**: The report indicates that multiple sentinel lymph nodes from both the left and right axillary regions were biopsied, and there is no evidence of metastatic disease in any of the lymph nodes. This is supported by negative cytokeratin immunohistochemical staining.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report.

Based on the AJCC staging system for breast cancer:
- **T (Tumor size and extent)**: The primary tumor is 7.0 cm in size, which corresponds to T3 (tumor more than 5 cm in greatest dimension).
- **N (Regional lymph nodes)**: N0, as there is no regional lymph node metastasis.
- **M (Distant metastasis)**: M0, as there is no distant metastasis.

The combination of T3, N0, and M0 corresponds to Stage IIB breast cancer according to the AJCC 8th edition staging system.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
36,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is described as invasive ductal carcinoma, poorly differentiated, with a size of 2.8 cm. According to the AJCC staging system, a tumor size greater than 2 cm but less than or equal to 5 cm is classified as T2.

2. **Regional Lymph Nodes (N):** The report indicates that no malignancy was seen in any of the sentinel lymph nodes examined (0/6), and the pathologic staging is pN0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** The report does not provide information on distant metastasis (MX), but typically, if there is no evidence of distant metastasis, it is considered M0.

Based on the provided information:
- The tumor size and characteristics classify it as T2.
- The absence of lymph node involvement classifies it as N0.
- The lack of information on distant metastasis, but assuming M0, aligns with early-stage cancer.

The combination of T2, N0, and M0 corresponds to Stage II according to the AJCC staging system for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
37,"## Answer
To determine the AJCC stage of the cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report describes a tumor in the left breast measuring 3.2 x 3.0 x 2.0 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report does not mention any lymph node involvement. The absence of lymph node involvement would be classified as N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which would be classified as M0.

Based on the information provided:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, a T2 N0 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
38,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The tumor size is given as 2.4 x 0 x 2.8 cm. For breast cancer staging, the T category is based on the largest dimension. Here, the largest dimension is 2.8 cm. According to AJCC, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates that 1 out of 10 axillary lymph nodes is positive for metastasis. This corresponds to N1, which is defined as metastasis to 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Combining these, we have T2, N1, M0. According to the AJCC 8th edition staging system for breast cancer, T2 N1 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
39,"## Answer
The pathology report provides the following information:

- **T Stage (Tumor size/extent):** T2, which indicates the tumor is more than 2 cm but not more than 5 cm in greatest dimension.
- **N Stage (Regional lymph nodes):** N0, which means there is no regional lymph node metastasis.
- **M Stage (Distant metastasis):** M0, indicating there is no distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I** typically involves T1, N0, M0.
- **Stage II** can involve T2, N0, M0 or T1, N1, M0, among other combinations.
- **Stage III** involves more advanced combinations such as T3 or N2, etc.
- **Stage IV** involves any T, any N, and M1.

Given the T2, N0, M0 classification, the cancer falls into **Stage II**.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
40,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The tumor is described as 3.3 x 1.8 x 3.2 cm. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates ""Metastases carcinomatosae in lymphonodis axillae (NO III/XVI)"" which means there are cancer metastases in 3 out of 16 axillary lymph nodes. This corresponds to N1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1a (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
41,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 2.8 x 2.6 cm. According to the AJCC staging system, a tumor size more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report states that 0 out of 10 lymph nodes are positive for metastasis. This indicates N0, meaning there is no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0, meaning no distant metastasis.

Based on the above information:
- T2 (tumor size more than 2 cm but not more than 5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer:
- T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
42,"## Answer
To determine the AJCC stage of the cancer, we need to consider several factors from the pathology report, including tumor size, lymph node involvement, and metastasis.

1. **Tumor Size (T):** The macroscopic description indicates a surgical specimen size of 5 x 4 x 2 cm. The minimum side margin is 0.2 cm. The tumor size is within the range for T2 (greater than 2 cm but not more than 5 cm).

2. **Lymph Node Involvement (N):** The report does not mention any lymph node involvement. In the absence of lymph node involvement, we assume N0.

3. **Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

4. **Histological Grade:** The histopathological diagnosis mentions NHG1, which corresponds to a low-grade tumor.

5. **Receptor Status:** The tumor is ER and PR positive, and HER2 negative, which is relevant for treatment but not directly for staging.

6. **Ki67 Proliferation Index:** The Ki67 index is 5%, indicating a low proliferation rate.

Based on the information provided:
- Tumor size suggests T2.
- No lymph node involvement suggests N0.
- No distant metastasis suggests M0.

According to the AJCC 8th edition staging system for breast cancer, a T2 N0 M0 tumor is classified as Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
43,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor Size (T):** The largest invasive tumor is 4.0 cm, which corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report states ""positive for metastatic carcinoma (2/16)"" in the right axillary lymph nodes, which corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Given the TNM classification: pT2 pN1a M0, we can determine the stage:

- **Stage I:** Typically involves T1 or T2 with N0 and M0.
- **Stage II:** Typically involves T2 with N1 and M0, or T3 with N0 or N1 and M0.
- **Stage III:** Typically involves T3 with N2 or N3, or T4 with any N, and M0.
- **Stage IV:** Involves any T, any N, and M1.

The classification pT2 pN1a M0 fits the criteria for Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
44,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size**: The tumor is 3.5 cm in greatest dimension, which corresponds to T2 in the AJCC staging system (T2: Tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement**: Ten lymph nodes were examined and all were negative for tumor involvement, which corresponds to N0 (no regional lymph node metastasis).

3. **Distant Metastasis**: The report does not provide information on distant metastasis (MX), but for staging purposes, we consider the absence of evidence of distant metastasis as M0.

Based on the above information, the pathologic stage is pT2 N0 M0. According to the AJCC staging system for breast cancer:

- **Stage I**: T1 N0 M0
- **Stage II**: T2 N0 M0 or T1 N1 M0
- **Stage III**: T3 N0 M0 or T2 N1 M0, etc.
- **Stage IV**: Any T, Any N, M1

The patient's cancer is classified as Stage II because it is T2 N0 M0.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
45,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive component of the tumor is 2.0 cm, which corresponds to T1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N):** There is metastatic adenocarcinoma in one of three sentinel lymph nodes, with a metastasis size of 5 millimeters and no extranodal invasion. This corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** The report states pMX, indicating that distant metastasis cannot be assessed from the current specimen.

Based on the AJCC staging system, the combination of T1c, N1a, and MX typically corresponds to Stage II cancer. Stage I would require no lymph node involvement (N0), and Stage III would require more extensive lymph node involvement or a larger tumor size. Stage IV would require confirmed distant metastasis, which is not indicated here.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
46,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 5.0 cm in largest dimension, which corresponds to T2 (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N):** There is metastatic carcinoma in 3 out of 26 lymph nodes, with extranodal extension noted in one of the nodes. This corresponds to pN1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** The report states MX, indicating that distant metastasis cannot be assessed.

4. **Stage Grouping:** The report explicitly mentions ""STAGE GROUPING IIB.""

Based on the AJCC staging system, a T2, N1, M0 classification corresponds to Stage IIB breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
47,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The gross tumor size is reported as 2.4 x 2.4 x 1.5 cm. According to AJCC staging, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The pathology report indicates metastatic adenocarcinoma in two of fourteen axillary lymph nodes (2/14). This corresponds to N1, which indicates metastasis in 1 to 3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (metastasis in 1 to 3 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1 M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
48,"## Answer
The pathology report provides the following key information:

1. **Tumor Size**: The tumor measures 2.4 x 2.4 x 2.4 cm.
2. **Histologic Type**: Infiltrating ductal carcinoma.
3. **Lymph Nodes**: 0 out of 10 lymph nodes are positive for metastasis, indicating no regional lymph node involvement.
4. **Distant Metastasis**: There is no mention of distant metastasis.

According to the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: Tumor size is 2 cm or less and no lymph node involvement.
- **Stage II**: Tumor size is between 2 cm and 5 cm, or there is involvement of 1 to 3 axillary lymph nodes.
- **Stage III**: Tumor size is more than 5 cm, or there is involvement of 4 or more axillary lymph nodes, or there is extension to the chest wall or skin.
- **Stage IV**: Any size tumor with distant metastasis.

In this case, the tumor size is 2.4 cm, which fits within the Stage II criteria. There is no lymph node involvement, which is consistent with Stage I, but the size of the tumor (greater than 2 cm) places it in Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
49,"## Answer
The pathology report provides the following key information:

1. **Tumor Characteristics**:
   - Type: Invasive poorly differentiated ductal carcinoma with lobular extension.
   - Size: 1.5x1.5x1.2 cm.
   - Grade: SBR Grade 3 (poorly differentiated).
   - Margins: Free of tumor.
   - Lymphovascular invasion: Absent.

2. **Lymph Node Status**:
   - Sentinel lymph nodes: 0/2 nodes are positive for tumor (negative for metastasis).

3. **Pathologic Stage**:
   - The report mentions ""Stage, Pathology: pT1c"". This indicates a primary tumor size greater than 1 cm but not more than 2 cm (T1c), with no regional lymph node metastasis (N0), and no distant metastasis (M0).

4. **Additional Findings**:
   - DCIS component present but less than 25%.
   - Hormone receptor status: ER, PR, and HER2 are all negative.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:
- **T1c**: Tumor size is more than 1 cm but not more than 2 cm.
- **N0**: No regional lymph node metastasis.
- **M0**: No distant metastasis.

Given these findings, the cancer is classified as Stage I, as it is a small tumor (T1c) with no lymph node involvement (N0) and no distant metastasis (M0).

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
50,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an infiltrating moderately differentiated ductal carcinoma with a size of 2.5 by 2.0 by 1.5 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report mentions micrometastatic ductal carcinoma in the right sentinel lymph node. Micrometastasis in lymph nodes is typically classified as N1mi (micrometastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size >2 cm but ≤5 cm)
- N1mi (micrometastasis in lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1mi M0 classification corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
51,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states that the tumor is 2.0 x 1.8 x 1.5 cm, which corresponds to a T1c classification (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report indicates that there is a single sentinel lymph node with isolated tumor cell clusters, classified as pN0(i+). This means there are isolated tumor cells, but no significant nodal metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 8th edition staging system for breast cancer:
- T1c
- N0(i+)
- M0

This combination typically corresponds to Stage I breast cancer, as isolated tumor cells in lymph nodes do not upstage the cancer to Stage II or higher.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
52,"## Answer
The pathology report provides the following key information for staging the cancer:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 1.2 cm, which corresponds to T1c (tumor more than 1 cm but not more than 2 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The sentinel lymph node biopsy is negative for metastases (0/1), indicating N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0 (no distant metastasis).

Based on the AJCC Cancer Staging Manual, 7th Edition, the pathological staging provided in the report is pT1c N0. This corresponds to Stage I breast cancer, as Stage I is defined by T1 (tumor ≤ 2 cm) and N0 (no regional lymph node metastasis) with M0 (no distant metastasis).

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
53,"## Answer
The pathology report provides detailed information about the cancer diagnosis and staging. Let's break down the key elements:

1. **Tumor Size and Type**: The report indicates an invasive ductal carcinoma, poorly differentiated (SBR Grade 3), with a tumor size of 3.5 cm in greatest dimension. This corresponds to a T2 classification in the AJCC staging system, as T2 is defined as a tumor more than 2 cm but not more than 5 cm in greatest dimension.

2. **Lymph Node Involvement**: The sentinel lymph nodes from the left axilla (nodes #1 to #4) are all negative for tumor cells (0/5 nodes involved). This corresponds to an N0 classification, indicating no regional lymph node metastasis.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, which would be classified as M0.

4. **Pathological Staging (pTN)**: The report explicitly states the pathological staging as pT2N0, which aligns with the findings above.

Based on the AJCC staging system, a T2N0M0 classification corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
54,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report states that the tumor is a poorly differentiated infiltrating duct carcinoma with a maximum microscopic dimension of 22 mm (2.2 cm). According to AJCC staging, a tumor size of 2.1 to 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report mentions that three sentinel lymph nodes were examined (Parts B, C, and D), and there was no evidence of metastatic disease in these nodes. This indicates N0, meaning no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0, meaning no distant metastasis.

Based on the above information:
- T2 (tumor size >2 cm but ≤5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2N0M0 classification corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
55,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification:

1. **Tumor Size (T):** The tumor size is 2.5 cm. According to the AJCC staging system for breast cancer, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The pathology report indicates that both sentinel lymph nodes are benign and negative for malignancy. Therefore, there is no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the pathology report, so we assume M0.

Based on the TNM classification:
- T2 (tumor size 2.5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2N0M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
56,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an invasive ductal carcinoma with a greatest dimension of 3.0 cm. According to AJCC staging, a tumor size of 2-5 cm corresponds to T2.

2. **Lymph Node Involvement (N):** The report states that there are two negative sentinel lymph nodes and two additional negative lymph nodes, totaling 0/4 lymph nodes involved. This corresponds to N0, indicating no regional lymph node metastasis.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size 2-5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system, a T2N0M0 breast cancer is classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
57,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The invasive component of the tumor is 1.6 cm, classified as invasive ductal carcinoma, apocrine type. The report also mentions a DCIS component with scattered foci up to 11 cm.

2. **Lymph Node Involvement**: All lymph nodes sampled (14 in total) are negative for cancer involvement (0/14).

3. **Metastasis**: There is no mention of distant metastasis, and the clinical stage is noted as cM0.

4. **AJCC Staging**: The report explicitly states the AJCC categories as Stage I, with a pTNM classification of pT1c, pN0, cM0.

Based on the AJCC staging system for breast cancer:
- **T1c** indicates a tumor size greater than 1 cm but not more than 2 cm.
- **N0** indicates no regional lymph node metastasis.
- **M0** indicates no distant metastasis.

Given these factors, the cancer is classified as Stage I, as it is a small tumor with no lymph node involvement or distant metastasis.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
58,"## Answer
The pathology report provides several key pieces of information that are crucial for determining the AJCC stage of the cancer:

1. **Tumor Size and Extent (T Stage):** The tumor measures 6.0 x 5.5 x 2.5 cm, with a maximum dimension of 6.0 cm. The report indicates a pathologic T stage of pT3, which corresponds to a tumor larger than 5 cm.

2. **Lymph Node Involvement (N Stage):** The report states that 27 out of 27 lymph nodes are positive for metastatic carcinoma, with extracapsular extension noted. This extensive lymph node involvement suggests a high N stage, likely N3, which indicates metastasis to 10 or more axillary lymph nodes or involvement of infraclavicular or supraclavicular lymph nodes.

3. **Distant Metastasis (M Stage):** There is no mention of distant metastasis in the report, which would be indicated by an M1 stage. Therefore, we assume M0, meaning no distant metastasis is present.

Based on the AJCC staging system:
- T3 indicates a tumor larger than 5 cm.
- N3 indicates extensive lymph node involvement.
- M0 indicates no distant metastasis.

Combining these, the cancer is classified as Stage III, as Stage III includes T3N1-3M0 or any T with N3M0.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
59,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 5.5 cm, which classifies it as T3 (tumor more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report states that 0 out of 10 axillary lymph nodes are positive for metastasis. This indicates N0 (no regional lymph node metastasis).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the AJCC staging system:
- T3, N0, M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
60,"## Answer
The pathology report provides the following key information:

1. **Tumor Size (pT):** The tumor measures 2.8 cm, which corresponds to pT2. According to the AJCC staging system, pT2 indicates a tumor size greater than 2 cm but not more than 5 cm.

2. **Lymph Node Involvement (pN):** The report states that the single lymph node examined is negative for metastatic disease, which corresponds to pN0.

3. **Distant Metastasis (pM):** The report mentions that distant metastasis cannot be assessed (pM0 or pMX).

Based on the AJCC staging system for breast cancer:

- **Stage I:** Typically involves a tumor size of 2 cm or less (pT1) and no lymph node involvement (pN0).
- **Stage II:** Can involve a tumor size greater than 2 cm but not more than 5 cm (pT2) with no lymph node involvement (pN0) or minimal lymph node involvement (pN1).
- **Stage III:** Generally involves larger tumors and/or more significant lymph node involvement.
- **Stage IV:** Involves distant metastasis.

Given the tumor size of 2.8 cm (pT2) and no lymph node involvement (pN0), the cancer fits the criteria for Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
61,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size (T), lymph node involvement (N), and presence of metastasis (M).

1. **Tumor Size (T):** The pathology report states ""Medullary carcinoma forming a 4.5 x 2.0 x 2.0 cm well-circumscribed mass (AJCC pT2)."" According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report mentions ""Multiple (5) left axillary sentinel lymph nodes are negative for tumor"" and ""AJCC pN0(i-)."" This indicates that there is no regional lymph node metastasis, which corresponds to N0.

3. **Distant Metastasis (M):** The report does not mention any distant metastasis, so we assume M0.

Based on the information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N0 (no regional lymph node metastasis)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer:
- T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
62,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (T):** The tumor is classified as pT4b due to skin ulceration. According to the AJCC staging system, T4b indicates a tumor of any size with direct extension to the chest wall and/or skin ulceration.

2. **Regional Lymph Nodes (N):** The report states pN0, meaning no regional lymph node metastasis was identified histologically. This indicates that the cancer has not spread to the lymph nodes.

3. **Distant Metastasis (M):** The report does not mention any distant metastasis, which implies M0.

Based on the AJCC staging system, a T4b tumor with N0 and M0 corresponds to Stage III breast cancer. Stage IV would require evidence of distant metastasis (M1), which is not present in this case.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
63,"## Answer
The pathology report provides the following key information for staging:

1. **Primary Tumor (pT):** The tumor is classified as pT2, which indicates a tumor size greater than 20 mm but less than 50 mm in greatest dimension. In this case, the tumor is 2.1 cm (21 mm).

2. **Regional Lymph Nodes (pN):** The report indicates pN0, meaning no regional lymph node metastasis was identified. Two sentinel lymph nodes were examined, and both were negative for carcinoma.

3. **Distant Metastasis (pM):** The report states ""Not applicable"" for distant metastasis, which implies there is no evidence of distant metastasis.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I** typically involves a tumor size of 2 cm or less (pT1) and no lymph node involvement (pN0).
- **Stage II** can involve a tumor size greater than 2 cm but less than 5 cm (pT2) with no lymph node involvement (pN0) or with limited lymph node involvement.
- **Stage III** involves larger tumors or more extensive lymph node involvement.
- **Stage IV** involves distant metastasis.

Given the tumor size (pT2) and the absence of lymph node involvement (pN0) and distant metastasis, the cancer fits the criteria for **Stage II**.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
64,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and the presence of metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 4 x 6 x 7 cm. According to the AJCC staging system, a tumor larger than 5 cm but not more than 7 cm is classified as T3.

2. **Lymph Node Involvement (N):** The report states that metastatic carcinoma is present in 3 lymph nodes (2 sentinel nodes and 1 of 9 axillary lymph nodes). This corresponds to N1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Combining these, the pathological stage is pT3 pN1a M0. According to the AJCC 8th edition staging system for breast cancer, this corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
65,"## Answer
The pathology report provides detailed information about the breast cancer diagnosis, including tumor size, lymph node involvement, and other relevant pathological findings. Let's break down the key elements:

1. **Tumor Size (T):** The largest invasive tumor focus is 2.9 cm, which corresponds to T2 in the AJCC staging system (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N):** The report indicates metastatic carcinoma in 25 out of 36 lymph nodes, with extranodal extension. This corresponds to N3, which is defined as metastasis in 10 or more axillary lymph nodes, or in infraclavicular (level III axillary) lymph nodes, or in clinically apparent ipsilateral internal mammary lymph nodes in the presence of one or more positive axillary lymph nodes, or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically apparent.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 7th Edition criteria:
- T2
- N3
- M0

The combination of T2, N3, and M0 corresponds to Stage III breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
66,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an invasive ductal carcinoma measuring 6 cm in the largest dimension. According to AJCC staging, a tumor larger than 5 cm but not more than 7 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report shows that 2 out of 4 lymph nodes are positive for metastatic carcinoma, with no extranodal extension. According to AJCC staging, 1-3 positive lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2 (tumor size > 5 cm but ≤ 7 cm)
- N1 (1-3 positive lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N1 M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
67,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The tumor is an infiltrating ductal carcinoma, grade III, with a size of 2.5 x 2.5 x 2 cm. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement**: The report states that multiple (3) right sentinel axillary lymph nodes and (2) right axillary lymph nodes are negative for tumor. This indicates that there is no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report, which corresponds to M0.

Based on the AJCC staging system, the combination of T2, N0, and M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
68,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Tumor Size (T):** The report indicates ""pT1c,"" which means the tumor is greater than 1 cm but not more than 2 cm in greatest dimension. This corresponds to T1c in the TNM staging system.

2. **Lymph Node Involvement (N):** The report states ""pN1a,"" which indicates metastasis in 1 to 3 axillary lymph nodes. This corresponds to N1 in the TNM staging system.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the TNM classification:
- T1c
- N1
- M0

According to the AJCC 8th edition staging system for breast cancer:
- Stage I: T1, N0, M0
- Stage II: T0-T2, N1, M0 or T2, N0, M0
- Stage III: T0-T2, N2, M0 or T3, N0-N2, M0 or any T, N3, M0
- Stage IV: Any T, Any N, M1

The classification of T1c, N1, M0 corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
69,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The report indicates an infiltrating ductal carcinoma with dimensions of 6.0 x 5.0 x 6.0 cm. According to AJCC staging, a tumor larger than 5 cm but not more than 7 cm is classified as T2.

2. **Lymph Node Involvement (N):** The sentinel lymph node #1 is positive for several micrometastases, approximately 0.1 cm each. Sentinel lymph node #2 and the non-sentinel lymph node are negative for metastatic tumor. Micrometastases in lymph nodes are typically classified as N1mi.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the above information:
- T2: Tumor size is greater than 5 cm but not more than 7 cm.
- N1mi: Micrometastases in lymph nodes.
- M0: No distant metastasis.

According to the AJCC staging system, a T2 N1mi M0 classification corresponds to Stage IIA.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
70,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size and Characteristics (T):**
   - The report mentions multiple foci of infiltrating lobular carcinoma with the largest mass being 1.8 x 1.3 x 1.2 cm.
   - The AJCC classification for the primary tumor is given as pT1c, which indicates a tumor size greater than 1 cm but not more than 2 cm in greatest dimension.

2. **Lymph Node Involvement (N):**
   - The report states that one of the three axillary sentinel lymph nodes is positive for micrometastasis, with the largest metastasis measuring 0.6 mm.
   - This is classified as pN1mi, indicating micrometastasis in the lymph nodes.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 8th edition staging system:
- T1c (tumor size >1 cm but ≤2 cm)
- N1mi (micrometastasis in lymph nodes)
- M0 (no distant metastasis)

The combination of T1c, N1mi, and M0 corresponds to Stage IIA breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
71,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report states ""Infiltrating ductal carcinoma... forming a multilobulated mass (1.5 x 1.2 x 1.0 cm)"" and is classified as ""AJCC pT1c"". According to AJCC, T1c indicates a tumor size greater than 1 cm but not more than 2 cm.

2. **Lymph Node Involvement (N):** The report mentions ""Multiple (3 of 25) left axillary lymph nodes are positive for metastatic carcinoma with extranodal extension (AJCC pN1)"". According to AJCC, pN1 indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0.

Based on the AJCC 8th edition staging system for breast cancer:
- T1c
- N1
- M0

This combination corresponds to Stage II breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
72,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive ductal carcinoma in the right breast measures 2.7 cm in greatest dimension. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates ""pN0(i+)"" which means there are isolated tumor cells (ITCs) in the lymph nodes, but no macrometastasis or micrometastasis. ITCs do not change the N stage from N0.

3. **Distant Metastasis (M):** The report states ""pMx,"" indicating that the presence of distant metastasis cannot be assessed from the pathology report.

Based on the TNM classification:
- T2: Tumor size is greater than 2 cm but not more than 5 cm.
- N0(i+): No regional lymph node metastasis, only isolated tumor cells.
- Mx: Distant metastasis cannot be assessed.

According to the AJCC staging system, a T2 N0 Mx classification corresponds to Stage II cancer, assuming no distant metastasis is found clinically.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
73,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the pathology report details:

1. **Tumor Size and Classification**: The report mentions two tumors with diameters of 2.8 cm and 0.8 cm. The larger tumor size of 2.8 cm is used for staging purposes. According to the AJCC staging system, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement**: The report indicates ""NO"" which suggests there is no regional lymph node involvement (N0).

3. **Distant Metastasis**: The report does not mention any distant metastasis, which implies M0.

4. **Overall Tumor Classification**: The report concludes with ""pT2(mult)NOLOVORO"". This confirms the tumor is classified as T2, with no lymph node involvement (N0), and no mention of metastasis (M0).

Based on the AJCC staging system:
- T2, N0, M0 corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
74,"## Answer
The pathology report provides detailed information about the cancer diagnosis and staging. Let's break down the key elements:

1. **Primary Tumor (T):** 
   - The left breast has an infiltrating ductal carcinoma, poorly differentiated, with a size of 6.0 cm. This is classified as pT3 because the tumor is greater than 5 cm in greatest dimension.

2. **Regional Lymph Nodes (N):**
   - Sentinel lymph nodes from both axillae were examined, and no carcinoma was seen in any of the nodes. Immunohistochemistry for keratin was negative, confirming no metastasis in the lymph nodes. This is classified as pN0.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, and it is marked as ""not applicable"" or ""Mn/a.""

4. **Final AJCC Staging:**
   - The report provides a final AJCC staging of pT3, snN0(i), Mn/a for the left breast cancer.

Based on the AJCC 7th edition staging system:
- **Stage I:** T1, N0, M0
- **Stage II:** T2 or T3, N0, M0
- **Stage III:** Any T, N1 or N2, M0
- **Stage IV:** Any T, Any N, M1

Given the classification of pT3, N0, M0, the cancer falls into Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
75,"## Answer
To determine the AJCC stage of breast cancer, we need to consider the tumor size (T), lymph node involvement (N), and the presence of distant metastasis (M).

1. **Tumor Size (T):** The tumor size is given as 2.2 x 1.5 x 5 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates that 3 out of 5 axillary lymph nodes are positive for metastasis. According to AJCC staging, involvement of 1-3 axillary lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (1-3 positive axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
76,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** The pathology report indicates a tumor size of 5.7 x 4.8 x 2.1 cm, which corresponds to AJCC pT3. According to AJCC staging, T3 indicates a tumor larger than 5 cm.

2. **Lymph Node Involvement (N):** The report states that 14 of 16 axillary lymph nodes are positive for metastatic carcinoma, which corresponds to AJCC pN3. N3 indicates metastasis in 10 or more axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the AJCC staging system:
- T3
- N3
- M0

This combination of T3, N3, and M0 corresponds to Stage III cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
77,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size and Characteristics**: The report mentions ""NEILTRATING DUCTAL CARCINOMA, NOT OTHERWISE SPECIFIED. 6.0."" This suggests a tumor size of 6.0 cm. The tumor is also described as ""POORLY DIFFERENTIATED INTERMEDIATE"" and ""EXTENDING TO WITHIN 1 MM OF LINE OF RESECTION,"" indicating a high-grade tumor with close margins.

2. **Lymph Node Involvement**: The report states ""THREE OF FIFTEEN: (3/15) AXILLARY LYMPH NODES POSITIVE FOR METASTATIC TUMOR WITH CAPSULAR AND EXTRACAPSULAR EXTENSION."" This indicates that 3 out of 15 axillary lymph nodes are positive for cancer, with evidence of extracapsular extension.

3. **Distant Metastasis**: There is no mention of distant metastasis in the report.

Based on the AJCC staging system:
- A tumor size greater than 5 cm with 1-3 positive lymph nodes typically corresponds to Stage IIB or Stage IIIA, depending on other factors like tumor grade and lymph node characteristics.
- The presence of extracapsular extension in the lymph nodes and the tumor's poor differentiation suggest a more advanced stage within these options.

Considering these factors, the most appropriate stage for this cancer, given the lymph node involvement and tumor characteristics, is likely Stage III.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
78,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and any distant metastasis.

1. **Tumor Size (T):** The report indicates a tumor size of 3.5 x 3 cm. According to the AJCC staging system, a tumor size more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report states that 9 out of 10 lymph nodes are positive for metastasis. This level of lymph node involvement is significant. According to the AJCC staging, N2 indicates metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis. Since 9 nodes are involved, this would be classified as N2.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size more than 2 cm but not more than 5 cm)
- N2 (metastasis in 4 to 9 axillary lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a T2 N2 M0 classification corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
79,"## Answer
The pathology report provides the following key information for staging the breast cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size (T):** The tumor is described as being 3.2 cm in greatest dimension. According to AJCC, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates metastatic ductal adenocarcinoma in two out of twelve axillary lymph nodes, with extracapsular extension. This corresponds to N1, which indicates metastasis to 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** The report lists MX, which means distant metastasis cannot be assessed. However, the absence of any mention of distant metastasis in the report suggests that there is no evidence of distant metastasis.

4. **Overall Stage:** The report explicitly states ""PTNM CLASSIFICATION: T2 N1 MX, STAGE IIB."" This classification aligns with the AJCC staging system, where T2 N1 M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
80,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Characteristics**: The tumor is described as multifocal invasive lobular carcinoma with a size of 1.7 x 1.2 x 1.5 cm. The tumor is classified as NHG2 (Nottingham Histologic Grade 2).

2. **Lymph Node Involvement**: There are metastases in the axillary lymph nodes, with 4 out of 10 nodes showing cancer involvement (NO IV/X).

3. **TNM Staging**: The report mentions pT1c and pN2a. 
   - **pT1c** indicates a primary tumor size greater than 1 cm but not more than 2 cm.
   - **pN2a** indicates metastasis in 4 to 9 axillary lymph nodes.

4. **Distant Metastasis**: There is no mention of distant metastasis (M0).

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:
- **Stage I**: Typically involves small tumors (T1) with no lymph node involvement (N0).
- **Stage II**: Involves larger tumors or limited lymph node involvement (N1).
- **Stage III**: Involves more extensive lymph node involvement (N2 or N3) or larger tumors.
- **Stage IV**: Involves distant metastasis (M1).

Given the information:
- The tumor size is consistent with T1c.
- The lymph node involvement is N2a (4-9 nodes involved).
- There is no evidence of distant metastasis.

Therefore, the cancer is classified as Stage III due to the N2a lymph node involvement.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
81,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the pathology report using the TNM classification system:

1. **Tumor Size (T):** The report states ""poorly differentiated invasive ductal breast carcinoma measuring a maximum of 3.4 cm."" The classification given is ""pT3."" However, this seems inconsistent because pT3 typically refers to tumors larger than 5 cm. Given the size of 3.4 cm, it should be pT2. However, we will proceed with the provided classification of pT3.

2. **Lymph Node Involvement (N):** The report mentions ""two axillary lymph node metastases (of 20 lymph nodes studied)"" and classifies this as ""pN1a (2/20)."" This indicates that there are metastases in 1-3 axillary lymph nodes, which corresponds to N1.

3. **Distant Metastasis (M):** The classification is ""M X,"" which means that the presence of distant metastasis cannot be assessed.

4. **Resection Margins (R):** The report states ""R 0,"" indicating no residual tumor after resection.

5. **Lymphovascular Invasion (L):** The report indicates ""L 1,"" meaning there is lymphatic invasion.

Based on the TNM classification:
- T3: Tumor >5 cm (though the report states 3.4 cm, we use the given classification)
- N1: Metastasis to 1-3 axillary lymph nodes
- M0 or MX: No distant metastasis assessed

According to the AJCC 8th Edition Staging System for breast cancer:
- Stage IIIA: T3 N1 M0

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
82,"## Answer
The pathology report provides the following key information for staging the breast cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size (T):** The largest invasive tumor is 3.8 cm in size, which corresponds to T2 (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N):** There is metastasis to one out of 38 lymph nodes, which corresponds to N1 (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so it is assumed to be M0 (no distant metastasis).

Based on the TNM classification:
- T2
- N1
- M0

According to the AJCC 8th Edition Cancer Staging Manual for breast cancer, a T2N1M0 classification corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
83,"## Answer
The pathology report provides the following key information:

1. **Tumor Size**: The invasive ductal carcinoma is 3.3x2.6x2.5 cm, which classifies it as T2 (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement**: There is micrometastatic carcinoma in one of the three sentinel lymph nodes (1/3), which classifies it as N1 (metastasis to 1-3 axillary lymph nodes).

3. **Distant Metastasis**: There is no mention of distant metastasis, so it is classified as M0.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **Stage I**: T1, N0, M0
- **Stage II**: T2, N0, M0 or T1, N1, M0
- **Stage III**: T2, N1, M0 or T3, N0, M0
- **Stage IV**: Any T, any N, M1

Given the classification of T2N1M0, the cancer is classified as Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
84,"## Answer
The pathology report provides several key pieces of information necessary for staging the breast cancer according to the AJCC (American Joint Committee on Cancer) guidelines:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 5.0 cm in largest dimension. According to AJCC, a tumor size greater than 2 cm but not more than 5 cm is classified as T2, and a tumor greater than 5 cm is classified as T3. Since the tumor is exactly 5.0 cm, it falls under T2.

2. **Lymph Node Involvement (N):** The report indicates that there is no evidence of metastatic tumor in the sentinel node or other examined lymph nodes (0/1 in sentinel node, 0/5 in level I, and 0/5 in level II). This means there is no regional lymph node involvement, which corresponds to N0.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, which implies M0.

Based on the TNM classification:
- T2 (tumor size >2 cm but ≤5 cm)
- N0 (no regional lymph node involvement)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer, a T2 N0 M0 classification corresponds to Stage II.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
85,"## Answer
To determine the AJCC stage of the cancer, we need to consider the TNM classification provided in the pathology report:

1. **Primary Tumor (T):** The report states ""Primary Tumor: pT2."" According to the AJCC staging system, pT2 indicates a tumor size greater than 2 cm but not more than 5 cm in greatest dimension.

2. **Regional Lymph Nodes (N):** The report states ""Regional Lymph Nodes: pN1a."" This indicates that there is metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node biopsy but not clinically apparent.

3. **Distant Metastasis (M):** The report states ""Distant Metastasis: Not applicable,"" which implies there is no distant metastasis (M0).

Based on the TNM classification:
- T2
- N1
- M0

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
86,"## Answer
To determine the AJCC stage of the breast cancer from the pathology report, we need to consider the tumor size, lymph node involvement, and presence of metastasis.

1. **Tumor Size (T):** 
   - The report mentions two lesions in the left breast: one measuring 2.6 x 1.7 x 1.5 cm and another measuring 3.0 x 2.8 x 2.5 cm. The larger tumor size is 3.0 cm, which corresponds to T2 (tumor size >2 cm but ≤5 cm).

2. **Lymph Node Involvement (N):**
   - The report indicates that there is lymphovascular invasion and multiple lymph nodes are positive for metastatic carcinoma. Specifically, 2 out of 2 lymph nodes are positive, 1 out of 1 sentinel lymph node is positive, and 5 out of 11 axillary lymph nodes are positive, with three showing extracapsular extension. This extensive lymph node involvement corresponds to N2 (4-9 axillary lymph nodes involved).

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size >2 cm but ≤5 cm)
- N2 (4-9 axillary lymph nodes involved)
- M0 (no distant metastasis)

According to the AJCC staging system for breast cancer, T2 N2 M0 corresponds to Stage IIIA.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
87,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T):** The invasive ductal carcinoma measures 2.2 cm. According to the AJCC staging system, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** There is metastatic carcinoma in one of the sentinel lymph nodes (sentinel lymph node #4) with extranodal extension. The report indicates 1 out of 13 lymph nodes is positive for metastasis. This corresponds to N1a, which indicates metastasis in 1-3 axillary lymph nodes.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so it is assumed to be M0.

Based on the TNM classification:
- T2 (tumor size >2 cm but ≤5 cm)
- N1a (metastasis in 1-3 axillary lymph nodes)
- M0 (no distant metastasis)

The combination of T2, N1a, and M0 corresponds to Stage IIA according to the AJCC 8th edition cancer staging manual for breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
88,"## Answer
The pathology report provides detailed information about the breast cancer diagnosis. Let's break down the key elements relevant to staging:

1. **Primary Tumor (T):** 
   - The report describes multiple masses in the left breast, with the largest being 3.2 x 2.2 x 1.4 cm. 
   - The tumor does not involve the nipple, overlying skin, or underlying chest wall, and all surgical resection margins are negative for invasive carcinoma by 1.2 cm.

2. **Regional Lymph Nodes (N):**
   - Multiple (10 of 19) left axillary lymph nodes are positive for metastatic carcinoma. 
   - The largest metastasis measures 11.0 mm. 
   - Extranodal extension is not present.

3. **Distant Metastasis (M):**
   - There is no mention of distant metastasis in the report.

Based on the AJCC (American Joint Committee on Cancer) staging system for breast cancer:

- **T2**: Tumor size is more than 2 cm but not more than 5 cm.
- **N2**: Metastasis in 4-9 axillary lymph nodes.
- **M0**: No distant metastasis.

Given the information, the cancer is classified as T2N2M0, which corresponds to Stage III breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
89,"## Answer
To determine the AJCC stage of breast cancer, we need to consider the tumor size (T), lymph node involvement (N), and the presence of distant metastasis (M).

1. **Tumor Size (T):** The tumor size is 2.7 x 2.7 x 2.7 cm. According to AJCC staging, a tumor size greater than 2 cm but not more than 5 cm is classified as T2.

2. **Lymph Node Involvement (N):** The report indicates 1 out of 11 axillary lymph nodes is positive for metastasis. According to AJCC staging, 1-3 positive axillary lymph nodes is classified as N1.

3. **Distant Metastasis (M):** There is no mention of distant metastasis in the report, so we assume M0 (no distant metastasis).

Based on the above information:
- T2 (tumor size > 2 cm but ≤ 5 cm)
- N1 (1-3 positive lymph nodes)
- M0 (no distant metastasis)

According to the AJCC 8th edition staging system for breast cancer, a combination of T2, N1, and M0 corresponds to Stage IIB.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
90,"## Answer
The pathology report provides the following key information for staging:

1. **Tumor Size (T stage):** The invasive ductal carcinoma is 1.5 cm in its greatest dimension. According to the AJCC staging system, a tumor size of more than 1 cm but not more than 2 cm is classified as T1c.

2. **Lymph Node Involvement (N stage):** The report indicates that 0 out of 4 sentinel lymph nodes are positive for tumor involvement, which corresponds to N0.

3. **Distant Metastasis (M stage):** The report states pMX, indicating that distant metastasis cannot be assessed, but there is no evidence of distant metastasis provided in the report.

Based on the above information:
- The T stage is T1c.
- The N stage is N0.
- The M stage is MX, but with no evidence of metastasis, we assume M0 for staging purposes.

According to the AJCC 8th Edition Cancer Staging Manual for breast cancer:
- T1c, N0, M0 corresponds to Stage I.

Therefore, the answer is - 
{""stage"" : ""Stage I""}"
91,"## Answer
The pathology report provides the following key information:

1. **Tumor Size and Type**: The invasive tumor is a large cell neuroendocrine carcinoma, high grade, with a maximum diameter of 3.8 cm. This size corresponds to a T2 classification in the AJCC staging system.

2. **Lymph Node Involvement**: There is no carcinoma identified in any of the four sentinel lymph nodes sampled (0/4), which corresponds to an N0 classification.

3. **Metastasis**: The report mentions ""pT2NOMX,"" indicating that distant metastasis cannot be assessed (MX). However, the final diagnosis section mentions ""metastatic high-grade neuroendocrine carcinoma"" in the right chest wall, which suggests the presence of distant metastasis.

Given the presence of metastatic disease, the cancer is classified as Stage IV according to the AJCC staging system, regardless of the T and N classifications.

Therefore, the answer is - 
{""stage"" : ""Stage IV""}"
92,"## Answer
To determine the AJCC stage of the cancer, we need to consider the tumor size, lymph node involvement, and presence of metastasis as per the TNM classification system.

1. **Tumor Size (T):** The pathology report indicates a tumor size of 2.7 cm, which corresponds to T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension).

2. **Lymph Node Involvement (N):** The report states that there is one sentinel lymph node positive for metastatic carcinoma and one non-sentinel lymph node completely replaced by metastatic carcinoma. This corresponds to N1a (metastasis in 1-3 axillary lymph nodes).

3. **Distant Metastasis (M):** The report mentions MX, which means distant metastasis cannot be assessed. However, there is no indication of distant metastasis in the report.

Based on the TNM classification:
- T2
- N1a
- MX

According to the AJCC staging system, a T2 N1a MX classification corresponds to Stage IIB breast cancer.

Therefore, the answer is - 
{""stage"" : ""Stage II""}"
93,"## Answer
To determine the AJCC stage of the cancer, we need to interpret the provided pathology report using the TNM classification system:

1. **Tumor Size (T):** The report states ""tumor diameter: 8 cm"" and classifies it as ""pT3"". According to the AJCC staging system, T3 indicates a tumor larger than 5 cm but not more than 10 cm.

2. **Lymph Nodes (N):** The report states ""N0"", which means there is no regional lymph node metastasis.

3. **Metastasis (M):** The report does not mention distant metastasis, and typically, if not mentioned, it is assumed to be M0 (no distant metastasis).

4. **Overall Stage:** 
   - For breast cancer, Stage III can be characterized by T3 N0 M0, among other combinations. 
   - Stage I and II typically involve smaller tumors or limited lymph node involvement.
   - Stage IV involves distant metastasis (M1).

Given the classification of pT3N0M0, this aligns with Stage III breast cancer according to the AJCC staging system.

Therefore, the answer is - 
{""stage"" : ""Stage III""}"
